McDermott Will & Schulte has advised Servier on the acquisition of BN104 from BioNova.Servier, an international, independent pharmaceutical group governed by a foundation, has completed the…
Servier Acquires Menin Inhibitor BN104 from BioNova


McDermott Will & Schulte has advised Servier on the acquisition of BN104 from BioNova.Servier, an international, independent pharmaceutical group governed by a foundation, has completed the…
…